179 related articles for article (PubMed ID: 24076587)
21. Microtubule-associated protein 1B light chain (MAP1B-LC1) negatively regulates the activity of tumor suppressor p53 in neuroblastoma cells.
Lee SY; Kim JW; Jeong MH; An JH; Jang SM; Song KH; Choi KH
FEBS Lett; 2008 Aug; 582(19):2826-32. PubMed ID: 18656471
[TBL] [Abstract][Full Text] [Related]
22. RNA silencing of checkpoint regulators sensitizes p53-defective prostate cancer cells to chemotherapy while sparing normal cells.
Mukhopadhyay UK; Senderowicz AM; Ferbeyre G
Cancer Res; 2005 Apr; 65(7):2872-81. PubMed ID: 15805289
[TBL] [Abstract][Full Text] [Related]
23. PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21.
Hu F; Gartenhaus RB; Eichberg D; Liu Z; Fang HB; Rapoport AP
Oncogene; 2010 Oct; 29(40):5464-74. PubMed ID: 20622899
[TBL] [Abstract][Full Text] [Related]
24. Effect of hydroxyurea on the promoter occupancy profiles of tumor suppressor p53 and p73.
Huang V; Lu X; Jiang Y; Wang JY
BMC Biol; 2009 Jun; 7():35. PubMed ID: 19558638
[TBL] [Abstract][Full Text] [Related]
25. Cell context dependent p53 genome-wide binding patterns and enrichment at repeats.
Botcheva K; McCorkle SR
PLoS One; 2014; 9(11):e113492. PubMed ID: 25415302
[TBL] [Abstract][Full Text] [Related]
26. RhoGAPs attenuate cell proliferation by direct interaction with p53 tetramerization domain.
Xu J; Zhou X; Wang J; Li Z; Kong X; Qian J; Hu Y; Fang JY
Cell Rep; 2013 May; 3(5):1526-38. PubMed ID: 23684608
[TBL] [Abstract][Full Text] [Related]
27. Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses.
Yoon KA; Nakamura Y; Arakawa H
J Hum Genet; 2004; 49(3):134-140. PubMed ID: 14986171
[TBL] [Abstract][Full Text] [Related]
28. apoB and apobec1, two genes key to lipid metabolism, are transcriptionally regulated by p53.
Ashur-Fabian O; Har-Zahav A; Shaish A; Wiener Amram H; Margalit O; Weizer-Stern O; Dominissini D; Harats D; Amariglio N; Rechavi G
Cell Cycle; 2010 Sep; 9(18):3761-70. PubMed ID: 20890106
[TBL] [Abstract][Full Text] [Related]
29. NDRG1 is necessary for p53-dependent apoptosis.
Stein S; Thomas EK; Herzog B; Westfall MD; Rocheleau JV; Jackson RS; Wang M; Liang P
J Biol Chem; 2004 Nov; 279(47):48930-40. PubMed ID: 15377670
[TBL] [Abstract][Full Text] [Related]
30. Adenosine promotes GATA-2-regulated p53 gene transcription to induce HepG2 cell apoptosis.
Yaguchi T; Nakano T; Gotoh A; Nishizaki T
Cell Physiol Biochem; 2011; 28(4):761-70. PubMed ID: 22178888
[TBL] [Abstract][Full Text] [Related]
31. p53 amplifies Toll-like receptor 5 response in human primary and cancer cells through interaction with multiple signal transduction pathways.
Shatz M; Shats I; Menendez D; Resnick MA
Oncotarget; 2015 Jul; 6(19):16963-80. PubMed ID: 26220208
[TBL] [Abstract][Full Text] [Related]
32. Functional characterisation of p53 mutants identified in breast cancers with suboptimal responses to anthracyclines or mitomycin.
Berge EO; Huun J; Lillehaug JR; Lønning PE; Knappskog S
Biochim Biophys Acta; 2013 Mar; 1830(3):2790-7. PubMed ID: 23246812
[TBL] [Abstract][Full Text] [Related]
33. SCH529074, a small molecule activator of mutant p53, which binds p53 DNA binding domain (DBD), restores growth-suppressive function to mutant p53 and interrupts HDM2-mediated ubiquitination of wild type p53.
Demma M; Maxwell E; Ramos R; Liang L; Li C; Hesk D; Rossman R; Mallams A; Doll R; Liu M; Seidel-Dugan C; Bishop WR; Dasmahapatra B
J Biol Chem; 2010 Apr; 285(14):10198-212. PubMed ID: 20124408
[TBL] [Abstract][Full Text] [Related]
34. The effect of non-coding DNA variations on P53 and cMYC competitive inhibition at cis-overlapping motifs.
Kin K; Chen X; Gonzalez-Garay M; Fakhouri WD
Hum Mol Genet; 2016 Apr; 25(8):1517-27. PubMed ID: 26908612
[TBL] [Abstract][Full Text] [Related]
35. Ribosomal protein S27L is a direct p53 target that regulates apoptosis.
He H; Sun Y
Oncogene; 2007 Apr; 26(19):2707-16. PubMed ID: 17057733
[TBL] [Abstract][Full Text] [Related]
36. Whole genome and normalized mRNA sequencing reveal genetic status of TK6, WTK1, and NH32 human B-lymphoblastoid cell lines.
Revollo J; Petibone DM; McKinzie P; Knox B; Morris SM; Ning B; Dobrovolsky VN
Mutat Res Genet Toxicol Environ Mutagen; 2016 Jan; 795():60-9. PubMed ID: 26774668
[TBL] [Abstract][Full Text] [Related]
37. S-phase sensing of DNA-protein crosslinks triggers TopBP1-independent ATR activation and p53-mediated cell death by formaldehyde.
Wong VC; Cash HL; Morse JL; Lu S; Zhitkovich A
Cell Cycle; 2012 Jul; 11(13):2526-37. PubMed ID: 22722496
[TBL] [Abstract][Full Text] [Related]
38. The novel p53 target TNFAIP8 variant 2 is increased in cancer and offsets p53-dependent tumor suppression.
Lowe JM; Nguyen TA; Grimm SA; Gabor KA; Peddada SD; Li L; Anderson CW; Resnick MA; Menendez D; Fessler MB
Cell Death Differ; 2017 Jan; 24(1):181-191. PubMed ID: 27834950
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA NEAT1 is a transcriptional target of p53 and modulates p53-induced transactivation and tumor-suppressor function.
Idogawa M; Ohashi T; Sasaki Y; Nakase H; Tokino T
Int J Cancer; 2017 Jun; 140(12):2785-2791. PubMed ID: 28295289
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional activation of the carboxylesterase 2 gene by the p53 pathway.
Choi W; Cogdell D; Feng Y; Hamilton SR; Zhang W
Cancer Biol Ther; 2006 Nov; 5(11):1450-6. PubMed ID: 16963839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
